Cargando…
Rifampin-Associated Renal Failure
Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617427/ https://www.ncbi.nlm.nih.gov/pubmed/37908633 http://dx.doi.org/10.7326/aimcc.2022.1200 |
_version_ | 1785129600936837120 |
---|---|
author | Miller, Kathleen Rennke, Helmut Richardson, Eugene |
author_facet | Miller, Kathleen Rennke, Helmut Richardson, Eugene |
author_sort | Miller, Kathleen |
collection | PubMed |
description | Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of rifampin-induced acute renal failure due to heme pigment–related injury in a patient who was receiving daily rifampin as therapy for latent tuberculosis. The patient case illustrates considering rifampin as a potential cause of acute renal failure when no other cause is identified. |
format | Online Article Text |
id | pubmed-10617427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
record_format | MEDLINE/PubMed |
spelling | pubmed-106174272023-10-31 Rifampin-Associated Renal Failure Miller, Kathleen Rennke, Helmut Richardson, Eugene Ann Intern Med Clin Cases Article Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to acute interstitial nephritis. We report a case of rifampin-induced acute renal failure due to heme pigment–related injury in a patient who was receiving daily rifampin as therapy for latent tuberculosis. The patient case illustrates considering rifampin as a potential cause of acute renal failure when no other cause is identified. 2023-04 2023-04-18 /pmc/articles/PMC10617427/ /pubmed/37908633 http://dx.doi.org/10.7326/aimcc.2022.1200 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access: This is an open access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND), which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. See: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Article Miller, Kathleen Rennke, Helmut Richardson, Eugene Rifampin-Associated Renal Failure |
title | Rifampin-Associated Renal Failure |
title_full | Rifampin-Associated Renal Failure |
title_fullStr | Rifampin-Associated Renal Failure |
title_full_unstemmed | Rifampin-Associated Renal Failure |
title_short | Rifampin-Associated Renal Failure |
title_sort | rifampin-associated renal failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617427/ https://www.ncbi.nlm.nih.gov/pubmed/37908633 http://dx.doi.org/10.7326/aimcc.2022.1200 |
work_keys_str_mv | AT millerkathleen rifampinassociatedrenalfailure AT rennkehelmut rifampinassociatedrenalfailure AT richardsoneugene rifampinassociatedrenalfailure |